INCYTE CORPORATION Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
INCYTE CORPORATION (INCY) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $24.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-02-10
- INCYTE CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $24.00K, a 66.20% decline from fiscal 2024.
- INCYTE CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $71.00K, a 66.03% decline from fiscal 2023.
- INCYTE CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $209.00K, a 100.96% increase from fiscal 2022.
- INCYTE CORPORATION unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $104.00K, a 9.47% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2025-12-31 | $24.00K 10-K · filed 2026-02-10 |
| 2024-12-31 | $71.00K 10-K · filed 2026-02-10 |
| 2023-12-31 | $209.00K 10-K · filed 2025-02-10 |
| 2022-12-31 | $104.00K 10-K · filed 2024-02-13 |
| 2021-12-31 | $95.00K 10-K · filed 2023-02-07 |
| 2020-12-31 | $201.00K 10-K · filed 2022-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |